Gone long on GFRD, short term to med term trade?.
Following a very strong trading statement last month, Panmure Gordon's analyst, Mark Hughes, is confident that not only will Galliford Try report a "strong" set of first half interim results, but that it will upgrade full-year forecasts.
He forecasts a pre-tax profit of £25.5 million, with net debt coming in at £70 million.
The stock is the most undervalued stock in the sector, trading on a 2012 price to earnings ratio of about 8.5 times, a 45% discount to the sector. The stock also offers a dividend yield of about 4.5%.
http://www.iii.co.uk/articles/25853/week-ahead